TickerFactsScreenerDevelopers

NORTHWEST BIOTHERAPEUTICS INC (NWBO) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

1996: -$1.34M1997: -$4.17M1998: -$9.22M1999: -$14.79M2000: -$22.52M2001: $16.93M2002: $4.88M2003: $15.0K2004: -$5.22M2005: -$11.42M2006: -$5.95M2007: $5.81M2008: -$12.30M2009: -$20.69M2010: -$27.68M2011: -$52.17M2012: -$16.07M2013: -$9.82M2014: -$35.03M2015: -$4.68M2016: -$26.50M2017: -$67.33M2018: -$48.13M2019: -$45.05M2020: -$362.95M2021: -$123.99M2022: -$128.10M2023: -$65.77M2024: -$94.49M2025: -$60.28M-$60.28M
1996Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025-$60.28M+36.2%
2024-$94.49M-43.7%
2023-$65.77M+48.7%
2022-$128.10M-3.3%
2021-$123.99M+65.8%
2020-$362.95M-705.6%
2019-$45.05M+6.4%
2018-$48.13M+28.5%
2017-$67.33M-154.1%
2016-$26.50M-466.7%
2015-$4.68M+86.7%
2014-$35.03M-256.8%
2013-$9.82M+38.9%
2012-$16.07M+69.2%
2011-$52.17M-88.5%
2010-$27.68M-33.8%
2009-$20.69M-68.2%
2008-$12.30M-311.8%
2007$5.81M+197.6%
2006-$5.95M+47.9%
2005-$11.42M-118.9%
2004-$5.22M-34880.0%
2003$15.0K-99.7%
2002$4.88M-71.2%
2001$16.93M+175.2%
2000-$22.52M-52.2%
1999-$14.79M-60.4%
1998-$9.22M-120.9%
1997-$4.17M-211.7%
1996-$1.34M—